Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satsuki Mochizuki

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Cancer Research|October 19, 2006
ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3Yoko Mitsui, Satsuki Mochizuki, Takahide Kodama, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
CCN1 (Cyr61) Is Overexpressed in Human Osteoarthritic Cartilage and Inhibits ADAMTS-4 (Aggrecanase 1) ActivityMiyuki Chijiiwa, Satsuki Mochizuki, Tokuhiro Kimura, et al.
Annals of Surgical Oncology|July 28, 2021
Mesothelin Expression is Correlated with Chemoresistance in Stage IV Colorectal CancerKen Nagata, Eiji Shinto, Takehiro Shiraishi, et al.
Digestion|November 14, 2019
Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal CancerSatsuki Mochizuki, Tadakazu Ao, Takumi Sugiura, et al.
Oncotarget|December 31, 2015
High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cellsShigeki Nanjo, Hiromichi Ebi, Sachiko Arai, et al.
Arthritis and Rheumatism|March 4, 2008
ADAM-12 (meltrin alpha) is involved in chondrocyte proliferation via cleavage of insulin-like growth factor binding protein 5 in osteoarthritic cartilageAiko Okada, Satsuki Mochizuki, Taku Yatabe, et al.
The Journal of Pathology|May 21, 2009
Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomasShuji Mikami, Ken-ichi Katsube, Mototsugu Oya, et al.
International Journal of Cancer|January 30, 2010
ADAM28 is a serological and histochemical marker for non-small-cell lung cancersHiroaki Kuroda, Satsuki Mochizuki, Masayuki Shimoda, et al.
Cancer Science|December 17, 2017
ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell deathMari Ueno, Takayuki Shiomi, Satsuki Mochizuki, et al.
The FEBS Journal|February 27, 2016
ADAM28 is expressed by epithelial cells in human normal tissues and protects from C1q-induced cell deathYuka Miyamae, Satsuki Mochizuki, Masayuki Shimoda, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Cancer Research|October 19, 2006
ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3Yoko Mitsui, Satsuki Mochizuki, Takahide Kodama, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
CCN1 (Cyr61) Is Overexpressed in Human Osteoarthritic Cartilage and Inhibits ADAMTS-4 (Aggrecanase 1) ActivityMiyuki Chijiiwa, Satsuki Mochizuki, Tokuhiro Kimura, et al.
Annals of Surgical Oncology|July 28, 2021
Mesothelin Expression is Correlated with Chemoresistance in Stage IV Colorectal CancerKen Nagata, Eiji Shinto, Takehiro Shiraishi, et al.
Digestion|November 14, 2019
Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal CancerSatsuki Mochizuki, Tadakazu Ao, Takumi Sugiura, et al.
Oncotarget|December 31, 2015
High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cellsShigeki Nanjo, Hiromichi Ebi, Sachiko Arai, et al.
Arthritis and Rheumatism|March 4, 2008
ADAM-12 (meltrin alpha) is involved in chondrocyte proliferation via cleavage of insulin-like growth factor binding protein 5 in osteoarthritic cartilageAiko Okada, Satsuki Mochizuki, Taku Yatabe, et al.
The Journal of Pathology|May 21, 2009
Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomasShuji Mikami, Ken-ichi Katsube, Mototsugu Oya, et al.
International Journal of Cancer|January 30, 2010
ADAM28 is a serological and histochemical marker for non-small-cell lung cancersHiroaki Kuroda, Satsuki Mochizuki, Masayuki Shimoda, et al.
Cancer Science|December 17, 2017
ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell deathMari Ueno, Takayuki Shiomi, Satsuki Mochizuki, et al.
The FEBS Journal|February 27, 2016
ADAM28 is expressed by epithelial cells in human normal tissues and protects from C1q-induced cell deathYuka Miyamae, Satsuki Mochizuki, Masayuki Shimoda, et al.
Pageof 6